Skin and systemic inflammation in adults with atopic dermatitis before and after whole‐body topical betamethasone 17‐valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Documents similaires

• Infant palmar hyperlinearity and type 2 inflammatory markers predict atopic dermatitis at 1 year of age
  par: Iben Frier Ruge, et autres
  Publié: (2025)
• Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open‐labeled single‐blinded randomized controlled trial
  par: Disha Chakraborty, et autres
  Publié: (2024)
• Genetic variations and clinical features associated with burning sensation due to topical tacrolimus in patients with atopic dermatitis
  par: Ju Yeong Lee, et autres
  Publié: (2024)
• Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
  par: Emma Guttman‐Yassky, et autres
  Publié: (2024)
• Are topical steroids beneficial or harmful in the treatment of atopic dermatitis?
  par: Tripdatabase
  Publié: (2025)